Condition
Pre-eclampsia
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 47 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
47 shownClinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 in Pregnancy and Pre-EclampsiaNCT07595016 · 2026-05-11
RECRUITINGPROTECT-Africa: Biomarker Validation for Preeclampsia TriageNCT07810439 · 2026-02-05
RECRUITINGPlacental Biology in Health and DiseaseNCT07470320 · 2025-12-16
RECRUITINGVitamin D for Preventing Recurrent Preeclampsia in Pregnant WomenNCT07288801 · 2025-08-09
RECRUITINGPRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)NCT07263490 · 2024-10-21
RECRUITINGLimPrOn: Limburg Pre-eclampsia InvestigationNCT03509272 · 2016-05-01
RECRUITINGOphthalmic Artery Doppler in the Puerperium After Hypertensive Disorders of Pregnancy (OPHELIA-PP)NCT07841795 · 2027-01-01
NOT_YET_RECRUITINGUsability Evaluation of Gen AI-based Nutrition Chatbot for Pregnant WomenNCT07458997 · 2026-10-01
NOT_YET_RECRUITINGGestational Changes in Hemodynamics and Respiratory Mechanics in Association With Pre-EclampsiaNCT07695909 · 2026-10-01
NOT_YET_RECRUITINGPharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety Lead-In for Dosing in Pregnant Women With Severe Pre-eclampsiaNCT07327255 · 2026-06-01
NOT_YET_RECRUITINGOxford Luteal Dysfunction and Placental Insufficiency StudyNCT07072052 · 2026-05-01
NOT_YET_RECRUITINGPrevalence of Blood Pressure Complications During Cesarean Section in Pre-eclamptic Patients (HOPE)NCT06588023 · 2024-09-05
UNKNOWNStudy of Pregnancy Pathologies Associated With Placental AbnormalitiesNCT05188066 · 2022-01-06
NOT_YET_RECRUITINGMidazolam Efficacy/Safety in Pre-Eclamptic C-Section SedationNCT07021521 · 2021-04-05
COMPLETEDClinical Effectiveness of First Trimester Pre-eclampsia Screening Program.NCT04021680 · 2019-06-10
UNKNOWNMaternal Serum Markers Predicting Preeclampsia At Early GestationsNCT05131282 · 2019-01-01
COMPLETEDPlacental Growth Factor Assessment of Women With Suspected Pre-eclampsiaNCT02881073 · 2017-06-29
COMPLETEDEvaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE)NCT02801695 · 2017-02-20
COMPLETEDThe Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of PregnancyNCT02891174 · 2016-12-01
COMPLETEDDietary Intervention Program for Pre-eclampsia in Women at RiskNCT02706158 · 2016-04-01
UNKNOWNSaccadic Reaction Time and Preterm Pre-eclampsiaNCT02613793 · 2016-01-01
TERMINATEDEvaluating the Effects of SMS Text Messaging Support System Among Frontline Health Workers in GhanaNCT02468310 · 2015-08-10
COMPLETEDAssessment of a Syringe Pump to Pre-eclamptic Women in a Low-resource HospitalNCT02296931 · 2015-03-01
COMPLETEDThoracic Ultrasonography for Pulmonary Edema in Patients With Pre-EclampsiaNCT02357264 · 2015-02-01
COMPLETEDESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy OutcomesNCT02218931 · 2014-09-12
COMPLETEDInduction With Foley OR Misoprostol (INFORM) StudyNCT01801410 · 2013-12-01
COMPLETEDIMproved PRegnancy Outcome by Early DetectionNCT01891240 · 2013-11-01
UNKNOWNCommunity Level Interventions for Pre-eclampsiaNCT01911494 · 2013-09-01
COMPLETEDNew Magnesium Sulphate Protocol for Pre-eclampsiaNCT01846156 · 2013-05-01
COMPLETEDSafety and Efficacy of RLX030 in Pregnant Women With Pre- EclampsiaNCT01566630 · 2013-05-01
TERMINATEDOxfordshire Women and Their Children's HealthNCT02419898 · 2013-04-01
UNKNOWNRandomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.NCT02050529 · 2012-10-01
COMPLETEDPhenylephrine Versus Ephedrine in Pre-eclampsiaNCT02025426 · 2012-09-01
TERMINATEDImproving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE)NCT01480544 · 2012-08-01
COMPLETEDA Modernized Approach to Prenatal Care in Low Risk WomenNCT01606774 · 2012-07-01
COMPLETEDPrevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery DopplersNCT01729468 · 2012-06-27
COMPLETEDEG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth RestrictionNCT01490489 · 2011-07-11
COMPLETEDRandom Urine Protein-creatinin Ratio to Predict Magnitude of ProteinuriaNCT01623791 · 2011-05-01
UNKNOWNA Retrospective Analysis of Neevo® and NeevoDHA® Compared to a Standard Prenatal Vitamin in Anemia During PregnancyNCT01193192 · 2010-07-01
TERMINATEDObservational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During PregnancyNCT00930397 · 2009-07-01
COMPLETEDInvestigating the Novel Observation of Right-left Difference in Uterine Artery Vascular Resistance in Pre-eclampsiaNCT00848679 · 2009-03-01
WITHDRAWNAssessment of Physical Exercise Using Stationary Bicycle for Pregnant Women With Risk for Preeclampsia DevelopmentNCT01395342 · 2008-01-01
COMPLETEDEarly Placental Insufficiency ScreeningNCT01348711 · 2007-05-01
TERMINATEDDisease Modification in Toxaemia of PregnancyNCT00175695 · 2004-12-01
COMPLETEDSildenafil Citrate for the Treatment of Established Pre-EclampsiaNCT00141310 · 2004-09-01
TERMINATEDEfficacy Study of Digibind for Treatment of Severe PreeclampsiaNCT00158743 · 2004-02-01
COMPLETEDRandomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe PreeclampsiaNCT00004399 · 1995-09-01
COMPLETEDCommon interventions
magnesium sulfateDRUG3PlaceboDRUG30 mg/kg Midazolam (Control Group)DRUG10.01 mg/kg Midazolam GroupDRUG10.02 mg/kg Midazolam GroupDRUG10.03 mg/kg Midazolam GroupDRUG11500 mg Calcium and 1200 IU Vitamin D for 2 monthsDIETARY_SUPPLEMENT1a culturally tailored nutrition AI chatbot for pregnant womenBEHAVIORAL1AcetaminophenDRUG1Anti-digoxin antibody (FAB fragment)DRUG1AspirinDRUG1balanced dietBEHAVIORAL1Blood pressure measurementDEVICE1blood sample and doppler Ultrasound of uterine arteriesOTHER1Blood test of PE riskDIAGNOSTIC_TEST1Blood test of Preterm PE riskDIAGNOSTIC_TEST1CitrullineDRUG1Community EngagementBEHAVIORAL1EG-101DRUG1EphedrineDRUG1Epidural lidocaineDRUG1Epidural lidocaine 2%DRUG1Exercise using stationary bicycleOTHER1Experimental: Treatment 1OTHER1Experimental: Treatment 2OTHER1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Duke University
2
Oxford University Hospitals NHS Trust
2
University Hospital, Tours
2
University of British Columbia
2
University of Oxford
2
Africa Clinical Research Network (ACRN)
1
Antonios Likourezos
1
Assistance Publique - Hôpitaux de Paris
1
BTG International Inc.
1
Cairo University
1
Copenhagen University Hospital, Hvidovre
1
Cukurova University
1
Dow University of Health Sciences
1
Evergreen Therapeutics, Inc.
1
Far Eastern Memorial Hospital
1
Trial status mix
COMPLETED22
NOT_YET_RECRUITING6
RECRUITING6
TERMINATED6
UNKNOWN6
WITHDRAWN1
Phase mix
NA13
PHASE26
PHASE34
PHASE44
PHASE13
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.